COMMUNIQUÉS West-GlobeNewswire
-
Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor
22/04/2026 -
Altimmune Announces Proposed Underwritten Public Offering of Securities
22/04/2026 -
PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
22/04/2026 -
LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia
22/04/2026 -
George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of risk for recurrent stroke by almost 40% with GMRx2 in patients with previous intracerebral hemorrhage
22/04/2026 -
RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
22/04/2026 -
Sight Sciences Announces the Release of its Sustainability Report
22/04/2026 -
Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
22/04/2026 -
BBOT Presents Preclinical Data Demonstrating pan-KRAS Inhibitor BBO-11818 Has Robust Anti-Tumor Activity in KRAS-Mutant Preclinical Models at the AACR Annual Meeting 2026
22/04/2026 -
Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée
22/04/2026 -
Mind Lab Pro Unveiled: Does This “Universal Nootropic” Really Improve Focus, Memory & Brain Power? Read Mind Lab PRO Report!
22/04/2026 -
Ipsen S.A. - Informations concernant la tenue de l’Assemblée Générale Mixte du 13 mai 2026
22/04/2026 -
Romeo Orthopaedics Welcomes Lauren Hennessy, MPAS, PA‑C, to Their Esteemed Team
22/04/2026 -
EssilorLuxottica: Q1 2026 Revenue - Revenue rising 10.8% in Q1. Third consecutive quarter of double-digit growth
22/04/2026 -
Providence Saint John’s Study Finds Lifestyle Program Improves Brain Health in Patients with Early Cognitive Impairment
22/04/2026 -
EssilorLuxottica: Chiffre d'affaires T1 2026 - Chiffre d'affaires en hausse de +10,8 % au premier trimestre. Troisième trimestre consécutif de croissance à deux chiffres
22/04/2026 -
Ipsen S.A. - Information relating to the holding of the Combined Shareholders’ Meeting of 13 May 2026
22/04/2026 -
MedShop Direct Expands White Glove Delivery and Installation of Adjustable Medical Beds for Assisted Living and Home Care Across 48 States
22/04/2026 -
Coloplast A/S - H1 2025/26 Earnings Release - Invitation for conference call on 12 May 2026 at 11:00 CEST
22/04/2026
Pages